Targeting c-MET to Enhance the Efficacy of Olaparib in Prostate Cancer

Targeting c-MET to Enhance the Efficacy of Olaparib in Prostate Cancer

Zhenwei Wang,1,2 Zhihong Dai,1,* Bingwei Wang,2 Yuren Gao,1 Xiang Gao,1 Liang Wang,1 Sihai Zhou,1 Liqin Yang,1 Xiaofu Qiu,2,3,* Zhiyu Liu1 1Department of Urinary Surgery, Second Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of Urolog...

Full description

Bibliographic Details
Main Authors: Wang Z, Dai Z, Wang B, Gao Y, Gao X, Wang L, Zhou S, Yang L, Qiu X, Liu Z
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:OncoTargets and Therapy
Subjects:
combination therapy
parp inhibitor
pha665752
prostate cancer
Online Access:https://www.dovepress.com/targeting-c-met-to-enhance-the-efficacy-of-olaparib-in-prostate-cancer-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/targeting-c-met-to-enhance-the-efficacy-of-olaparib-in-prostate-cancer-peer-reviewed-fulltext-article-OTT

Similar Items